After 10 years as Associate Professor in Maternal – Fetal Medicine at the Free University in Amsterdam, Gus migrated to Adelaide. He is the Clinical Director of the Women and Children’s Division of the Northern Adelaide Health Service (Lyell McEwin Hospital and Modbury Hospital), and Professor in Obstetrics & Gynaecology with The University of Adelaide, Northern Campus. His academic PhD Thesis Erasmus entitled ‘Prediction and Prevention of Pregnancy-Induced Hypertensive Disorders. A Clinical and Pathophysiologic Study’; included the world’s first prospective RCT on low-dose Aspirin in the prevention of preeclampsia. His areas of specific interest align firmly with the Still Awaremission of ending preventable stillbirth and adverse pregnancy outcome. Gus has been highly successful in translating basic science progress into preventative strategies that really changed clinical obstetrics. His work is widely published with 231 publications to his name.
Gus is one of the founders of the SCOPE group with his Adelaide collaborators has successfully completed the clinical part of the Australian contribution to the global SCOPE study; the largest ever program aimed at developing robust clinically useful predictors for preeclampsia, preterm labour and intra-uterine growth restriction. His clinical work involves maternal-fetal medicine and obstetric medicine. He is nationally and internationally recognised as one of the leading experts in the fields of preeclampsia and thrombophilias and adverse pregnancy outcome. He has been instrumental in transforming the Department of Obstetrics and Gynaecology of the Lyell McEwin Hospital from a district hospital maternity service into what is now recognised as one of the most innovating and evidence based departments in South Australia with the largest number of training medical officers.